UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 原発性中枢神経系リンパ腫の臨床症状、病理学的特徴、および診断 clinical presentation pathologic features and diagnosis of primary central nervous system lymphoma
2. 末梢神経腫瘍 peripheral nerve tumors
3. 非ホジキンリンパ腫の臨床症状および診断 clinical presentation and diagnosis of non hodgkin lymphoma
4. 二次性中枢神経系リンパ腫の臨床症状および診断 clinical presentation and diagnosis of secondary central nervous system lymphoma
5. 非ホジキンリンパ腫の評価および病期分類 evaluation and staging of non hodgkin lymphoma

English Journal

Progressive neurolymphomatosis with cutaneous disease: Response in a patient with mycosis fungoides.

Hanna R, Di Primio GA, Schweitzer M, Torres C, Sheikh A, Chakraborty S.SourceDepartment of Medical Imaging, The Ottawa Hospital - General Campus, 501 Smyth Road, Ottawa, ON, Canada, K1H 8L6, rhanna@toh.on.ca.
Skeletal radiology.Skeletal Radiol.2013 Jul;42(7):1011-5. doi: 10.1007/s00256-013-1595-6. Epub 2013 Mar 27.
Peripheral neurolymphomatosis is a rare manifestation of advanced lymphoproliferative disorders. It is often associated with B cell lymphomas and rarely with cutaneous T cell lymphomas, such as mycosis fungoides and Sézary syndrome. In this case report, we present a 78-year-old male with a long-sta
PMID 23532558

Hothi DK, Rees L, McIntyre CW, Marek J.SourceDepartment of Nephro-Urology, Great Ormond Street Hospital for Children, London, UK.
Nephron. Clinical practice.Nephron Clin Pract.2013 Jun 21;123(1-2):83-92. [Epub ahead of print]
In adults, recurrent hemodialysis (HD)-induced cardiac injury results in ischemic myocardial dysfunction. Uremic children, like adults, share the full complement of uremia-related cardiovascular abnormalities but without significant atheromatous coronary artery disease. The aim of this study was, to
PMID 23796960

原田斉子,冨田稔,木村暁夫 [他],香村彰宏,林祐一,保住功,兼村信宏,森脇久隆,祖父江元,犬塚貴
日本内科学会雑誌 101(1), 157-160, 2012-01-10
… Neurolymphomatosisは脳神経を含む末梢神経，神経根あるいは神経叢へのリンパ腫の浸潤を呈する，臨床的には稀な疾患とされている1）．今回，寛解導入後に末梢神経障害をきたし，神経生検によりneurolymphomatosisと診断し得たB cell lymphomaの2例を経験した．悪性リンパ腫の寛解導入後であっても末梢神経障害を呈した場合には，neurolymphomatosisを鑑別に入れ，神経生検を考慮する必要があ …
NAID 10030391408